Australia News
-
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
Australia, with its 2011 revenue of $13 billion, occupies the second largest share of the Asia Pacific pharma market fol...Read more
-
Innova, TGR to co-market ELISA technology
Australia | News | By BioSpectrum Bureau | 0 Comment | 20 Jan, 2014
Singapore: Australia-based, TGR BioSciences, a life sciences company focused on the development of rapid, high sensitivi...Read more
-
Alchemia appoints new chairman
Australia | Influencers | By BioSpectrum Bureau | 0 Comment | 11 Feb, 2014
Singapore: Alchemia, Australia based drug discovery and development company, has appointed Mr. Santo J. Costa as non-exe...Read more
-
Bionomics, Merck Serono end agreement
Australia | News | By BioSpectrum Bureau | 0 Comment | 15 Jun, 2012
Singapore: Australian company Bionomics and Merck Serono, a division of Merck, Darmstadt Germany, have mutually ended t...Read more
-
AstraZeneca, Alchemia sign $240 mn drug deal
Australia | News | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2013
Singapore: Alchemia signed a multi-target, drug discovery collaboration with AstraZeneca. The collaboration includes the...Read more
-
Victoria court approves Biota's merger with Nabi Biopharma
Australia | News | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2012
Singapore: The Supreme Court of Victoria has approved the scheme of arrangement between Biota Holdings and the holders o...Read more
-
Eisai gets approval for Halaven in Australia
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 10 Sep, 2012
Singapore: Eisai Australia, a subsidiary of the Japanese firm Eisai, has received approval from the Australian Departme...Read more
-
GI Dynamics starts US trial of EndoBarrier
Australia | News | By BioSpectrum Bureau | 0 Comment | 16 Jan, 2013
Singapore: GI Dynamics has initiated its US multicenter pivotal clinical trial of EndoBarrier, the Endo trial, for the ...Read more
-
Pharmaxis for Prix Galien UK award
Australia | News | By BioSpectrum Bureau | 0 Comment | 01 Jul, 2014
Singapore: Six companies have been short listed for this year's internationally recognised Prix Galien award UK Orphan D...Read more
-
Genome of extinct frog revived for fresh egg
Australia | News | By BioSpectrum Bureau | 0 Comment | 18 Mar, 2013
Singapore: The genome of an extinct Australian frog has been revived and reactivated by a team of scientists using sophi...Read more
-
Protagonist, Ironwood expand peptide R&D deal
Australia | News | By BioSpectrum Bureau | 0 Comment | 21 Dec, 2012
Singapore: US-based Protagonist Therapeutics and Australia-based Ironwood Pharmaceuticals expanded their research collab...Read more
-
Luminex restructures, shuts down Australian office
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 Aug, 2013
Singapore: Luminex entered a restructuring plan focused on its assay and related products (ARP) segment's newborn screen...Read more
-
Lonza produces Bionomics' stem cell cancer drug
Australia | News | By BioSpectrum Bureau | 0 Comment | 25 Apr, 2013
Singapore: Bionomics has initiated manufacturing activities for BNC101, its lead anti-cancer stem cell candidate followi...Read more
-
Irish firm's track-&-trace system to curb fake drugs
Australia | News | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2013
Singapore: Horizon, an Irish engineerng consultancy firm, has completed testing of its new tracking system that aims at ...Read more
-
iSonea launches asthma monitoring device in Australia
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Sep, 2013
Singapore: Australian medical technology company, iSonea, launched AirSonea wheeze monitoring device, in the Australian ...Read more
-
Will the next blockbuster emerge from Asia?
Australia | Opinion | By Nandita Singh | 0 Comment | 17 Oct, 2012
Blockbusters and super profits. Will the bioscience industry in this decade see these words come to life? More important...Read more
-
One compound to kill all known malarial strains
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2012
Singapore: A recently discovered compound from the aminopyridine class could be a potential single-dose cure for all str...Read more
-
Bionomics seeks $4.2 mn R&D tax incentive
Australia | News | By BioSpectrum Bureau | 0 Comment | 16 Jan, 2013
Singapore: Bionomics has lodged its FY 2012 tax return and registered with AusIndustry (on behalf of Innovation Austral...Read more
